Revaprazan Hydrochloride
Catalog No. A17506
Revaprazan hydrochloride is a novel acid pump antagonist (APA). Revaprazan hydrochloride reduces COX-2 expression and has significant anti-inflammatory actions activities in H. pylori infection.
Catalog Num | A17506 |
---|---|
M. Wt | 398.91 |
Formula | C22H24ClFN4 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 178307-42-1 |
Synonyms | Revaprazan Hydrochloride; YH 1885; YH-1885; YH1885 |
SMILES | Cl.CC1N(CCc2ccccc12)c3nc(Nc4ccc(F)cc4)nc(C)c3C |
Revaprazan hydrochloride is a novel acid pump antagonist (APA). Revaprazan hydrochloride reduces COX-2 expression and has significant anti-inflammatory actions activities in H. pylori infection.
In vitro | DMSO | 14 mg/mL (35.1 mM) | |
Water | |||
Ethanol | |||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 25.07 mL | 125.34 mL | 250.68 mL |
0.5 mM | 5.01 mL | 25.07 mL | 50.14 mL |
1 mM | 2.51 mL | 12.53 mL | 25.07 mL |
5 mM | 0.5 mL | 2.51 mL | 5.01 mL |
*The above data is based on the productmolecular weight 398.91. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.